Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

How Are The Shorts Trading Apple Inc. (AAPL)?

If you’re an Apple Inc. (NASDAQ:AAPL) investor, should you care about short data?

In the financial blogosphere, there are tons of indicators for Apple traders to track, but it’s key to take note of a stock’s short sellers. Some indicators we can use are: (a) the percentage of a stock’s tradable shares that the shorts are presently short selling, plus (b) the change in short interest.

Increased short selling usually indicates what it implies: the market’s big players have turned less optimistic about the stock. Overselling, though, may have a positive effect on share price, as the shorts can be forced to buy their positions.

Within our database, it is not a secret that we monitor the smart money’s sentiment, but it is eqaully as beneficial to combine this information with overall short information. In certain instances, big time players could share that they’re bearish on a company, but it’s not an SEC requirement. Nevertheless, some retail players may wish to stay away from heavily shorted companies with above-average hedgie interest, while others may prefer short-squeeze opportunities. For readers looking for a market-beating piggybacking strategy, discover the details of our premium strategy.

Let us take a look at the recent info swirling around Apple Inc. (NASDAQ:AAPL).

Looking at the latest FINRA data, which is reported twice monthly, we can discover that Apple has a short interest of 2.20% of float. This indicates a -19% change from the prior filing period. With a total float of 908.12M shares, this reveals a short ratio of 2.00.

It’s also important to take note of hedge fund holdings from their 13F forms. Of the funds we track, Ken Griffin’s Citadel Investment Group had the largest call position in Apple Inc. (NASDAQ:AAPL), worth close to $1.9421 billion, accounting for GREENLIGHT CAPITAL David Einhorn3.4% of its total 13F portfolio. The 2nd biggest stake is held by D E Shaw, managed by D. E. Shaw, which held a $1.4017 billion position; the fund has 2.6% of its 13F portfolio invested in the stock. Some other peers with similar optimism include David Einhorn’s Greenlight Capital, Philippe Laffont’s Coatue Management and Ken Fisher’s Fisher Asset Management.

Also, insider trading activity, especially when it’s bullish, is most useful when the company in focus has experienced transactions within the past 180 days. Over the last half-year time period, Apple Inc. (NASDAQ:AAPL) has seen zero unique insiders purchasing, and 7 insider sales (see the details of insider trades here).

Let’s also examine activity in other stocks similar to Apple Inc. (NASDAQ:AAPL). These stocks are Hewlett-Packard Company (NYSE:HPQ), Google Inc (NASDAQ:GOOG), International Business Machines Corp. (NYSE:IBM), Microsoft Corporation (NASDAQ:MSFT), and Dell Inc. (NASDAQ:DELL). All of these stocks are in the personal computers industry and their market caps are similar to AAPL’s market cap.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.